Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating activities
Net earnings	$ 337	$ 928	$ 822
Adjustments to reconcile net earnings to cash provided by (used in) operating activities:
Depreciation and amortization	654	655	668
Curtailment gain	0	0	(63)
Changes in assets and liabilities:
Accounts receivable	160	(291)	(89)
Inventories	(229)	(18)	(141)
Accounts payable	180	37	14
Accrued advertising and promotions	76	46	74
Accrued expenses and current liabilities	(230)	46	(43)
Taxes deferred and payable, net	239	(116)	(42)
Accrued pension and postretirement benefits	(58)	(43)	(129)
Employee compensation	36	(38)	8
Other	99	(3)	146
Cash provided by operating activities	1,264	1,203	1,225
Investing activities
Capital expenditures	(684)	(660)	(689)
Proceeds from sale of assets and business	61	63	37
Change in restricted cash	66	24	47
Purchase of held to maturity securities	(173)	0	0
Proceeds from held to maturity securities	113	0	0
Investment in related businesses	(35)	(12)	(70)
Other	(3)	(3)	(6)
Cash used in investing activities	(655)	(588)	(681)
Financing activities
Proceeds from borrowings of long-term debt	691	1,012	531
Repayments of long-term debt	(564)	(522)	(283)
Net proceeds from short-term borrowings	367	55	(465)
Dividends paid	(312)	(294)	(269)
Repurchase of common stock	(750)	(525)	(250)
Purchase of noncontrolling interest shares	(5)	(25)	0
Common stock issued	34	26	38
Other	(14)	(5)	(9)
Cash used in financing activities	(553)	(278)	(707)
Effect of exchange rate changes on cash and cash equivalents	55	(24)	(91)
Increase (decrease) in cash and cash equivalents	111	313	(254)
Cash and cash equivalents at beginning of year	1,085	772	1,026
Cash and cash equivalents at end of year	1,196	1,085	772
Supplemental disclosure of cash flow information
Cash paid for interest	181	198	178
Cash paid for income taxes	$ 311	$ 300	$ 251